| Component: (Network and Table) | |
|---|---|
| Network | 00500 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (http://www.universalamerican.com/role/StatementConsolidatedStatementsOfCashFlows)  | 
| Table | (Implied) | 
| Reporting Entity [Axis] | 0001514128 (http://www.sec.gov/CIK) | 
| CONSOLIDATED STATEMENTS OF CASH FLOWS | Period [Axis] | ||
|---|---|---|---|
2016-01-01 - 2016-12-31  | 2015-01-01 - 2015-12-31  | 2014-01-01 - 2014-12-31  | |
CONSOLIDATED STATEMENTS OF CASH FLOWS  | |||
Operating activities:  | |||
Net income (loss)  | 55,376,000    | (163,969,000)   | (29,467,000)   | 
Income (loss) from discontinued operations  | (61,666,000)   | 160,273,000    | 2,859,000    | 
Loss from continuing operations  | (6,290,000)   | (3,696,000)   | (26,608,000)   | 
Adjustments to reconcile net income loss to cash (used for) provided by operating activities:  | |||
Deferred income taxes  | (  | (  | |
Net realized gains on investments  | (  | (  | (  | 
Realized (gain) loss on sale of business  | (  | ||
Amortization of intangible assets  | 933,000    | 2,110,000    | 2,600,000    | 
Amortization of debt issuance costs  | |||
Amortization of debt discount on convertible notes  | |||
Net amortization of bond premium  | |||
Depreciation expense  | |||
Stock based compensation expense  | |||
Changes in operating assets and liabilities:  | |||
Policy and contract claims  | (  | (  | (  | 
Reinsurance recoverables  | (  | ||
Due and unpaid/advance premiums  | (  | (  | |
Net amounts payable to discontinued operations  | |||
Income taxes receivable  | (  | ||
Other healthcare receivables  | (  | ||
Other, net  | (  | (  | |
Cash provided by operating activities of continuing operations  | |||
Cash (used for) provided by operating activities of discontinued operations  | (  | (  | |
Cash provided by (used for) operating activities  | (  | ||
Investing activities:  | |||
Proceeds from sale, maturity, call, paydown or redemption of fixed maturity investments  | |||
Cost of fixed maturity investments acquired  | (  | (  | (  | 
Change in short-term investments  | (  | ||
Proceeds of sale of cost method investments  | |||
Sale of business, net of cash sold  | |||
Purchase of fixed assets  | (  | (  | (  | 
Other investing activities  | (  | (  | |
Cash (used for) provided by investing activities of continuing operations  | (  | ||
Cash provided by investing activities of discontinued operations  | |||
Cash provided by investing activities  | |||
Financing activities:  | |||
Net proceeds from issuance of common and preferred stock, net of tax effect  | (  | (  | |
Share buyback/cancellation  | (  | (  | |
Dividends paid to stockholders  | (  | (  | |
Principal payment on loan payable  | (  | ||
Proceeds from the issuance of convertible senior notes  | |||
Payment of issue costs - convertible senior notes  | (  | ||
Distributions from discontinued operations  | (  | ||
Cash provided by (used for) financing activities of continuing operations  | (  | (  | |
Cash used for financing activities of discontinued operations  | (  | (  | |
Cash used for financing activities  | (  | (  | (  | 
Net increase (decrease) in cash and cash equivalents  | (  | ||
Less: decrease (increase) in cash and cash equivalents from discontinued operations  | (  | ||
Net increase (decrease) in cash and cash equivalents from continuing operations  | (  | ||
Cash and cash equivalents of continuing operations at beginning of period  | 70,546,000    | ||
Cash and cash equivalents of continuing operations at end of period  | 104,462,000    | 70,546,000    | 94,376,000    | 
Supplemental Cash Flow Information:  | |||
Interest payments  | |||
Cash paid (received) for income taxes  | (  | (  | |